Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | LAP3 | P28838 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28059855 | 0.96 | L3MBTL1 (0.47) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL29090042 | 0.87 | L3MBTL1 (0.49) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL464914 | 0.81 | SRC (0.48) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL28278294 | 0.80 | SRC (0.44) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL1072680 | 0.77 | SRC (0.48) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL9874206 | 0.76 | MAPK1 (0.47) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL31480676 | 0.76 | TSHR (0.49) | SRCALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL17544935 | 0.76 | ALDH1A1 (0.46) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| SCHEMBL13538051 | 0.76 | L3MBTL1 (0.52) | L3MBTL1SRCTDP1ALDH1A1MEN1 | |
| Triphenyl Phosphate SCHEMBL28231928 | 0.75 | SRC (0.56) | L3MBTL1SRCTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106604981-B | Lubricant compositions for improved thermo-oxidative stability and color stability | SK新技术株式会社 | 2020-02-07 | — | — | CN | claimed |
| US-11370775-B2 | Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors | Tseng, Yufeng Jane (US) | 2022-06-28 | — | — | US | disclosed |
| US-20200361894-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2020-11-19 | — | — | US | disclosed |
| CN-106604981-B | Lubricant compositions for improved thermo-oxidative stability and color stability | SK新技术株式会社 | 2020-02-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370775-B2 | Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors | DAO, DDO, IL4I1 | L3MBTL1 1732/4885SRC 3981/4885TDP1 1108/4885 |
| US-20200361894-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | DAO, DDO, DDC | L3MBTL1 877/4885SRC 3521/4885TDP1 814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.